Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$534,728
+$101,682 QoQ
Shares Held
3,412
+20.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#857
of 1,603 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Inscription Capital, LLC holds $24,225,985 across 10 Drug Manufacturers - General names. NVS ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,836 | $7,577,448 | |
| 2 | ABBV |
AbbVie Inc.
|
20,373 | $5,126,661 | |
| 3 | LLY |
ELI LILLY & Co
|
4,139 | $4,964,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,514 | $3,407,049 | |
| 5 | PFE |
Pfizer Inc
|
31,586 | $760,590 | |
| 6 | AMGN |
Amgen Inc
|
1,749 | $633,347 | |
| 7 | NVS |
Novartis AG
This page
|
3,412 | $534,728 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,910 | $493,989 |
All Filings in NVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $534,728 | 3,412 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $433,046 | 2,835 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $315,860 | 2,291 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $291,361 | 2,272 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $235,727 | 1,948 | Shares | Sole | 2025-08-12 | |
| 2021-06-30 | $620,979 | 6,806 | Shares | Sole | 2021-08-13 | |
| 2020-06-30 | $298,702 | 3,420 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $373,663 | 4,532 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||